dc.creatorBLANDE, Ivan Souza
dc.creatorBASSANEZE, Vinicius
dc.creatorLAVINI-RAMOS, Carolina
dc.creatorFAE, Kellen Cristhina
dc.creatorKALIL, Jorge
dc.creatorMIYAKAWA, Ayumi Aurea
dc.creatorSCHETTERT, Isolmar Tadeu
dc.creatorKRIEGER, Jose Eduardo
dc.date.accessioned2012-10-19T18:24:46Z
dc.date.accessioned2018-07-04T15:11:58Z
dc.date.available2012-10-19T18:24:46Z
dc.date.available2018-07-04T15:11:58Z
dc.date.created2012-10-19T18:24:46Z
dc.date.issued2009
dc.identifierTRANSFUSION, v.49, n.12, p.2680-2685, 2009
dc.identifier0041-1132
dc.identifierhttp://producao.usp.br/handle/BDPI/23176
dc.identifier10.1111/j.1537-2995.2009.02346.x
dc.identifierhttp://dx.doi.org/10.1111/j.1537-2995.2009.02346.x
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1619906
dc.description.abstractBACKGROUND: Mesenchymal stem cells (MSCs) have been considered for human regenerative therapy applications, and safe culture and expansion protocols are needed especially in the context of interspecies contamination. Human platelet lysate (PL) has been proposed as animal serum substitute during in vitro MSC expansion. In this work, a simplified and efficient method to obtain autologous PL to replace animal serum in cell culture applications is described. STUDY DESIGN AND METHODS: PL obtained by freezing and centrifugation procedures was tested as medium supplement for human adipose mesenchymal stem cell (hASC) culture. Differential proliferation, immunophenotypic changes, and differentiation under PL or fetal bovine serum (FBS) were assessed. RESULTS: In contrast to 10% FBS supplementation, cell population doubling time was significantly lower when hASCs were cultured with the same concentration of PL ( PL 22.9 +/- 1.5 hr vs. FBS 106.7 +/- 6.5 hr, t test, p < 0.05). Furthermore, hASCs maintained with 2.5% PL supplementation also showed satisfactory results. Immunophenotypic analysis revealed no differences between hASCs cultivated with PL or FBS supplementation and both cultures retained the potential to differentiate into adipose cells. These results demonstrate that autologous PL obtained from the same donor can be used as animal serum substitute in hASC culture. CONCLUSIONS: Taken together, evidence is provided that platelets provided by a single donor are sufficient to obtain PL for hASC propagation for clinical-scale applications mitigating the potential untoward side effects associated with the use of animal-derived reagents.
dc.languageeng
dc.publisherWILEY-BLACKWELL PUBLISHING, INC
dc.relationTransfusion
dc.rightsCopyright WILEY-BLACKWELL PUBLISHING, INC
dc.rightsrestrictedAccess
dc.titleAdipose tissue mesenchymal stem cell expansion in animal serum-free medium supplemented with autologous human platelet lysate
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución